Novartis Investigative Site

Eastbourne BN21 2UD

0 studies enrolling now · 2 studies all time

What they study most

Psoriatic Arthritis

Studies at this site

• Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis — Completed
• 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis — Completed